Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinic
about
Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive reviewEffects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis.A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunctionTadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbiditiesUrinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations.Tadalafil in the management of lower urinary tract symptoms: a review of the literature and current practices in Russia.Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.LUTS in pelvic ischemia: a new concept in voiding dysfunction.How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2.Current drug therapy of patients with BPH-LUTS with the special emphasis on PDE5 inhibitors.
P2860
Q26785752-539867B3-C06E-4EE0-B9F1-B747BD6A051BQ30751186-B957ABD2-F47C-4AD4-9E60-08AA667A56CEQ30987913-2104B8B2-719D-44C7-AFF3-6EF583FC2F91Q33744285-40461FAC-7B3D-4E74-8CF9-51C8C9176761Q35840149-35EE106A-3DD4-4237-B654-7234EE6D7A3BQ37466573-E3C13545-97A7-4405-BF30-EF3BAF0614FBQ38222740-58721F24-31FB-4269-B7CE-7A05C48E9446Q38241547-2F44AB18-8BAB-4630-97EF-4D6A14411B32Q38550856-A9D9C8CB-DA0B-4865-9C03-88A0DEFFA03FQ38704953-DD56E693-3754-427D-A452-190845D8F682Q38819020-53925D1D-E7EA-4F45-BFCB-044678AA408CQ39105942-34189B44-3CCD-46AC-8B14-BBE1F122E766
P2860
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinic
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@ast
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@en
type
label
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@ast
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@en
prefLabel
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@ast
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@en
P2093
P356
P1476
Effects of tadalafil on lower ...... bo-controlled tadalafil clinic
@en
P2093
Anne Esler
Claus G Roehrborn
Hartmut Porst
Lars Viktrup
Roberta J Secrest
P304
P356
10.1111/JSM.12212
P577
2013-06-19T00:00:00Z